Search - tctmd.com

Displaying 21 - 40 of 68

Sort: Relevancy | Date

Presentation TCT 2024

Early Lipid Lowering Therapy and Glycemic Control Agents: What’s Their Benefit in PAD Intervention

Presenter: Naomi Hamburg

October 29, 2024

Presentation TCT 2024

Real World Data in PAD

Presenter: Eric Secemsky

October 29, 2024

Presentation TCT 2024

Best CLI Medical Therapy Subgroup

Presenter: Matthew Menard

October 29, 2024

Presentation TCT 2024

TCT 698: Prevalence and Prognostic Impact of Clinical and Anatomical Characteristics Suggesting Complex Pad in Patients Undergoing Surgical vs Endovascular Revascularization

Presenter: Serdar Farhan

October 29, 2024

Presentation TCT 2024

Drug Delivery Technologies for the SFA: Where are We Now After the Paclitaxel Scare?

Presenter: Sahil Parikh

October 28, 2024

Presentation TCT 2024

Atherectomy/IVL: What is Optimal Lesion Preparation for the SFA?

Presenter: Ehrin Armstrong

October 28, 2024

Presentation TCT 2024

Scaffolds for the SFA: Will We Ever Have Anything Better Than Nitinol?

Presenter: Lawrence Garcia

October 28, 2024

Presentation TCT 2024

TCT 692: First Clinical Use of a Novel Forward-Shifted Peripheral Intravascular Lithotripsy System: Primary Outcomes of the Mini S/FORWARD PAD IDE Study

Presenter: John Corl

October 28, 2024

News Conference News TCT 2024

Radiation Survey Reveals Variable Practices as Operators Look to Themselves for Fixes

L.A. McKeown

October 27, 2024

News Conference News TCT 2024

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

Michael O'Riordan

October 27, 2024

Presentation TCT 2024

GDMT for PAD to Include Diabetes and Nutrition

Presenter: Bailey Estes

October 27, 2024

News Daily News

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

L.A. McKeown

October 23, 2024

News Daily News

Different Guidelines for Acute PE Offer a Mixed Bag of Advice

Caitlin E. Cox

October 08, 2024

News Conference News ESC 2024

New ESC Guidelines Merge PAD, Aortic Diseases Into Single Document

Caitlin E. Cox

September 10, 2024

News Opinion CV Team Dispatch

September 2024 Dispatch for the CV Team

L.A. McKeown

September 01, 2024

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

L.A. McKeown

August 26, 2024

News Daily News

Platelet Hyperreactivity Score May Improve CVD Risk Detection

L.A. McKeown

August 23, 2024

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

L.A. McKeown

August 19, 2024

News Daily News

Studies Highlight Rapid Growth of Semaglutide Use, Risks of Some Online Sources

Todd Neale

August 12, 2024

News Daily News

FDA Medical Devices Chief Jeff Shuren Announces Retirement

L.A. McKeown

July 24, 2024

Advertisement

Early Lipid Lowering Therapy and Glycemic Control Agents: What’s Their Benefit in PAD Intervention

Real World Data in PAD

Best CLI Medical Therapy Subgroup

TCT 698: Prevalence and Prognostic Impact of Clinical and Anatomical Characteristics Suggesting Complex Pad in Patients Undergoing Surgical vs Endovascular Revascularization

Drug Delivery Technologies for the SFA: Where are We Now After the Paclitaxel Scare?

Atherectomy/IVL: What is Optimal Lesion Preparation for the SFA?

Scaffolds for the SFA: Will We Ever Have Anything Better Than Nitinol?

TCT 692: First Clinical Use of a Novel Forward-Shifted Peripheral Intravascular Lithotripsy System: Primary Outcomes of the Mini S/FORWARD PAD IDE Study

Radiation Survey Reveals Variable Practices as Operators Look to Themselves for Fixes

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

GDMT for PAD to Include Diabetes and Nutrition

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

Different Guidelines for Acute PE Offer a Mixed Bag of Advice

New ESC Guidelines Merge PAD, Aortic Diseases Into Single Document

September 2024 Dispatch for the CV Team

Scientific Statement Reviews Current Antithrombotic Options in PAD

Platelet Hyperreactivity Score May Improve CVD Risk Detection

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

Studies Highlight Rapid Growth of Semaglutide Use, Risks of Some Online Sources

FDA Medical Devices Chief Jeff Shuren Announces Retirement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content